Literature DB >> 33649716

Covid Assossiated Invasive Fungal Sinusitis.

Susan K Sebastian1, Vibhor B Kumar1, Manu Gupta2, Yukti Sharma3.   

Abstract

Acute invasive fungal sinusitis is an aggressive infection affecting immunocomprosmised patients and carries a high mortality. Patients with Covid-pneumonia are at an increased risk of developing invasive pulmonary fungal infections probably due to their reduced immunological competence. Here, we review three cases of Covid-associated invasive fungal sinusitis. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  Covid-19; Immunocompromised state; Invasive fungal sinusitis

Year:  2021        PMID: 33649716      PMCID: PMC7905418          DOI: 10.1007/s12070-021-02471-6

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


Introduction

Invasive fungal diseases are life-threatening infections affecting patients in immunocompromised state. It has been reported in the past that patients under intensive care due to influenza and respiratory viral infections including Covid-pneumonia are at an increased risk of developing invasive pulmonary fungal infections probably due to their reduced immunological competence [1, 2]. Here, we review three cases of Covid-associated invasive fungal sinusitis (CAIFS) highlighting the diagnostic and therapeutic challenges encountered. To our knowledge, Covid-19 assossiated acute invasive fungal rhinosinusitis has not been reported before.

Case 1

59 year man admitted in intensive care unit (ICU) with bilateral Covid-pneumonia with ARDS and on mechanical ventilation for seven days developed nasal blockage, facial and periorbital swelling and blackening of middle turbinate with thick dirty nasal discharge. He was a post coronary artery by-pass grafting patient with well controlled diabetes mellitus and was receiving insulin, broad spectrum intravenous antibiotics, dexamethasone, heparin and other supportive measures. Tissue from middle meatus revealed dual infection of aspergillus fumigatus and Rhizopus on potassium hydroxide (KOH) test and fungal culture. Computed Tomography (CT) of paranasal sinuses revealed heterogenous opacification of bilateral maxillary, ethmoid, sphenoid and left frontal sinuses with involvement of left orbit (Fig. 1). After microbiological confirmation of CAIFS, liposomal Amphotericin B was given (total dose of 3050 mg). Subsequently he was continued on Voriconazole. Surgical debridement was done. Histopathology of sinus tissue confirmed the diagnosis of Mucormycosis. Progression of nasal disease halted, general condition improved and mechanical ventilation was discontinued. However, during the post-Covid recovery phase patient developed myocarditis with cardiac arrythmia and expired.
Fig. 1

Computed tomography paranasal sinuses. (Case-1)

Computed tomography paranasal sinuses. (Case-1)

Case 2

60 year man under ICU care for bilateral Covid pneumonia with ARDS, with diabetes mellitus and deranged kidney functions developed right eye pain, periorbital swelling, restricted eye movements and diminution of vision suggestive of orbital cellulitis with cavernous sinus thrombosis on the tenth day of admission. He was on insulin, broad spectrum intravenous antibiotics, dexamethasone and renal replacement therapy and required ventilatory and ionotropic support. Nasal endoscopy revealed blackening of the middle turbinate and the tissue from middle meatus revealed long aseptate, ribbon like hyphae suggestive of Zygomycosis on KOH test. Fungal culture confirmed the presence of Zygomycosis. Asymmetric soft tissue density in bilateral maxillary frontal, ethmoid and sphenoid sinuses were present on CT. He received a total dose of 850 mg of liposomal amphotericin B but surgical debridement could not be carried out because of the poor general condition and persistent septicemic shock and the patient expired on the fourteenth day.

Case 3

64 year man admitted from the emergency department with bilateral Covid-pneumonia wth ARDS in an altered sensorium, renal failure and shock developed proptosis of right eye with periorbital bluish discoloration on the ninth day of admission. He was a known case of diabetes mellitus under control and peptic ulcer. He received insulin, broad spectrum antibiotics, hydrocortisone and mechanical ventilation and renal replacement therapy. Blackening of the lateral wall of nose with crusts and discharge was observed on nasal endoscopy. Computed tomography of paranasal sinuses revealed evidence of sinusitis involving right maxillary, bilateral ethmoid and sphenoid sinuses. KOH test of nasal tissue revealed fungus with broad asepate branching hyphae suggestive of Zygomycosis. Unfortunately he developed massive peptic ulcer bleed and went into irreversible shock and expired on the tenth day of hospital stay. Antifungal treatment could not be initiated in this patient.

Discussion

Patients with Covid-19 pneumonia requiring intensive care, share risk factors and underlying diseases that make them vulnerable to invasive fungal infections [3, 4]. Uncontrolled diabetes mellitus especially diabetic ketoacidosis is a common predisposing illness [4] for acute invasive fungal rhinisinusitis. Although patients in this series had history of diabetes mellitus, none was in diabetic ketoacidosis and diabetes was well controlled in two patients and hence diabetes mellitus may not have been a strong predisposing factor in them. Renal failure was present in two and one patient had coronary artery disease in the past. In addition, it is important to consider that the use of corticosteroids which are prescribed for Covid related complications may potentially reduce immune response [5]. In this series, the already compromised immunological competence of the patients due to Covid infection could have been further worsened by comorbidities and steroids [5]. All patients in this study developed features of acute invasive fungal rhinosinusitis 10–15 days after the onset of Covid-illness which probably coincides with the phase of sepsis-induced immune suppression [2]. Clinical characteristics, relevant investigations and treatment details are given in Table 1. Patients in this study presented with features of rapid tissue invasion through nasal mucosa, bone, neurovascular structures and surrounding organs. Radiology was nonspecific and the diagnosis of invasive fungus was made initially by bedside endoscopic evaluation and direct microscopic evidence of fungal hyphae using 10% KOH test, which was later confirmed by mycology culture and histopathology which are reliable methods of diagnosis [4]. Histopathology revealed evidence of angio-invasion and lumenal thrombosis. Treatment of CAIFS consists of reversal of pre-disposing state, surgical debridement and antifungal therapy [4]. CAIFS is associated with rapid clinical worsening compromising aggressive anti-fungal treatment at times.
Table 1

Clinical profile

Case 1Case 2Case 3
Age/sex59/M60/M64/M
Covid statusCovid-19 RTPCR + Covid-19 RTPCR + Covid-19RTPCR + 
Clinical presentationCovid-pneumonia with ARDS, septicaemiaCovid- pneumonia, uncontrolled diabetes mellitus, deranged kidney functionsCovid -pneumonia, septicemia, shock, renal failure, altered sensorium
Features of invasive fungal diseaseFacial swelling, proptosis, thick nasal discharge, blackening of middle turbinate (left side)-10 days after the onset of Covid-illnessPeriorbital swelling, chemosis, restricted eye movements, diminution of vision, nasal discharge with blackening of middle turbinate and septum (right side)-15 days after the onset of illness

Proptosis of eye with periorbital discolouration, blackening of lateral nasal wall with thick nasal discharge (right side)—on the sixteenth day after the onset of Covid illness

Developed massive hemetemesis on the seventeenth day of illness

Co-morbiditiesDiabetes mellitus, hypertension, coronary artery disease (post-Coronary Artery Bypass Grafting)Diabetes mellitus, deranged kidney functionsDiabetes mellitus, renal failure, peptic ulcer
Predisposing conditions for invasive fungal infectionCOVID- pneumonia with ARDS, diabetes mellitus, steroid therapyCOVID-pneumonia with ARDS diabetes mellitus, renal failure steroid therapyCOVID- pneumonia with ARDS, diabetes mellitus, steroid therapy
Radiology Computed tomography-ThoraxBilateral non-lobar distribution of ground glass opacities with septal thickening involving lung parenchyma. Fibro-parenchymal scarring causing architectural distortion and bronchiectasis changes in left lobeBilateral peripheral distribution of ground glass opacities with septal thickening involving lung parenchyma. Few subpleural fibrotic bands in left lower lobe. Minimal pericardial effusionNon lobar distribution of ground glass opacities with septal thickening involving bilateral lung parenchyma
Computed tomography-Paranasal sinuses

Heterogeneous opacification of bilateral maxillary ethmoid, sphenoid and left frontal sinuses. Osteo-meatal complex, frontal recess. spheno-ethmoidal recess occluded on left side

Proptosis of left eye with bulky left inferior rectus muscle with retro-conal fat stranding

Soft tissue density in bilateral maxillary, ethmoid, frontal and sphenoid sinuses suggestive of pan sinusitisSoft tissue density in right maxillary, sphenoid and bilateral ethmoidal sinuses
Microbiology Potassium hydroxide test for fungusLong hyaline, septate branching hyphae and aseptate hyphae suggestive of dual infection with Aspergillus and mucormycosis seenLong aseptate, irregular, ribbonlike hyphae seen suggestiveof zygomycosisBroad septate hyphae seen in abundance suggestive of mucormycosis
Fungal cultureAspergillus fumigatus and Rhizopus grownZygomycosis growNot done
HistopathologyInvasive Fungal sinusitis-consistent with mucormycosisNot doneNot done
Treatment

Mechanical ventilation, vasopressors, renal replacement therapy

Broad spectrum antibiotics, steroids, insulin therapy

Mechanical ventilation,vasopressors,renal replacement therapy

Broad spectrum antibiotics, steroids, insulin therapy

Mechanical ventilation,vasopressors renal replacement therapy

Broad spectrum antibiotics, steroids, insulin therapy

Antifungal treatment:

Medical treatment

Liposomal Amphotericin B, VoriconazoleLiposomal Amphotericin BAntifungal agents not given
Surgical DebridementEndoscopic debridementNot doneNot done
OutcomeExpiredExpiredExpired
Clinical profile Proptosis of eye with periorbital discolouration, blackening of lateral nasal wall with thick nasal discharge (right side)—on the sixteenth day after the onset of Covid illness Developed massive hemetemesis on the seventeenth day of illness Heterogeneous opacification of bilateral maxillary ethmoid, sphenoid and left frontal sinuses. Osteo-meatal complex, frontal recess. spheno-ethmoidal recess occluded on left side Proptosis of left eye with bulky left inferior rectus muscle with retro-conal fat stranding Mechanical ventilation, vasopressors, renal replacement therapy Broad spectrum antibiotics, steroids, insulin therapy Mechanical ventilation,vasopressors,renal replacement therapy Broad spectrum antibiotics, steroids, insulin therapy Mechanical ventilation,vasopressors renal replacement therapy Broad spectrum antibiotics, steroids, insulin therapy Antifungal treatment: Medical treatment

Conclusion

COVID-19 infection is probably a predisposing factor for acute invasive fungal rhinosinusitis and is assossiated with a high mortality.
  8 in total

1.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

2.  Invasive Fungal Sinusitis During Active COVID-19 Infection.

Authors:  Michela Borrelli; Tasha Nasrollahi; Ruben Ulloa; Jonathan Raskin; Elisabeth Ference; Dennis M Tang
Journal:  Ear Nose Throat J       Date:  2022-06-30       Impact factor: 1.677

Review 3.  Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature.

Authors:  Manar M Ashour; Tougan T Abdelaziz; Doaa M Ashour; Anas Askoura; Mohamed Ibrahim Saleh; Mohammad S Mahmoud
Journal:  J Neuroradiol       Date:  2021-06-01       Impact factor: 3.447

4.  COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.

Authors:  Anusuya Bhattacharyya; Phulen Sarma; Hardeep Kaur; Subodh Kumar; Jaimini Bhattacharyya; Manisha Prajapat; Ajay Prakash; Saurabh Sharma; Dibbanti Harikrishna Reddy; Prasad Thota; Seema Bansal; Bhaswati Sharma Gautam; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2021 Nov-Dec       Impact factor: 1.200

Review 5.  COVID-19-associated mucormycosis of head-and-neck region: A systematic review.

Authors:  Mamata Kamat; Uma Datar; Sanjay Byakodi; Sharad Kamat; Varsha Vimal Kumar
Journal:  J Clin Transl Res       Date:  2022-01-03

Review 6.  The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.

Authors:  Nahid Akhtar; Atif Khurshid Wani; Surya Kant Tripathi; Ajit Prakash; M Amin-Ul Mannan
Journal:  Curr Res Biotechnol       Date:  2022-08-03

7.  Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?

Authors:  Amarjeet Kumar; Abhyuday Kumar; Neeraj Kumar; Ajeet Kumar; Chandni Sinha; Prabhat Kumar Singh
Journal:  Indian J Crit Care Med       Date:  2022-09

8.  Invasive Aspergillosis of Nose and Paranasal Sinus in COVID-19 Convalescents: Mold Goes Viral?

Authors:  Sandeep Shetty; C Shilpa; S Kavya; Anand Sundararaman; Kiran Hegde; Sriram Madhan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2022-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.